The role and value of real-world evidence in health technology decision-making in France, Germany, Italy, Spain, and the UK: insights on external control arms

22 April 2025 - Real-world evidence is increasingly used and accepted by health technology assessment (HTA) bodies as supportive evidence ...

Read more →

Real-world evidence to support health technology assessment and payer decision making: is it now or never?

31 March 2025 - The aim of this policy article is twofold: (i) to provide a summary and update of recent ...

Read more →

The use of real world data for estimating relative treatment effects in NICE health technology assessment submissions: a review

1 February 2025 - This paper investigates the current use of real world data for estimating relative treatment effects in NICE ...

Read more →

Acceptability of using real world data to estimate relative treatment effects in health technology assessments: barriers and future steps

15 May 2024 - Evidence about the comparative effects of new treatments is typically collected in randomised controlled trials (RCTs). In ...

Read more →

Can we use existing guidance to support the development of robust real world evidence for health technology assessment/payer decision-making?

2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...

Read more →

NICE recommends NHS collects real world evidence on devices that monitor people with Parkinson’s disease

27 September 2022 - Five promising technologies that could help improve symptoms and quality of life for people with Parkinson’s disease ...

Read more →

The (harsh) reality of real-world data external comparators for health technology assessment

8 July 2022 - We read with great interest the recently published article by Patel et al. and commend the authors ...

Read more →

Target trial emulation for transparent and robust estimation of treatment effects for health technology assessment using real world data: opportunities and challenges

25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials.  ...

Read more →

Aetion and NICE announce collaboration to explore use of real world evidence for comparative effectiveness studies to inform clinical guidance

6 October 2021 - Collaboration will leverage the Aetion Evidence Platform to study when and how real world evidence can support ...

Read more →

Do existing real world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal

28 April 2021 - Technological and computational advancements offer new tools for the collection and analysis of real world data.  ...

Read more →

NICE signs up to join the GetReal Institute

28 April 2021 -NICE’s ambition complements the GetReal Institute’s core mission to facilitate the adoption and implementation of real-world evidence ...

Read more →

Real world evidence to support payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

3 September 2020 - There are divergent views on the potential of real world data to inform decisions made by regulators, ...

Read more →

NICE partners with Flatiron Health to develop real world evidence research methodologies

14 July 2020 - Collaboration will help NICE expand use of real world data in service of better outcomes for UK ...

Read more →

Real world evidence use in assessments of cancer drugs by NICE

10 July 2020 - Single technology assessments published by NICE from April 2011 to October 2018 that evaluated cancer treatments were ...

Read more →

NICE explores extending its use of data to inform its guidance

25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...

Read more →